drugset / Trial / NCT02131350

Combination Treatment of Intravitreal Ranibizumab, Focal/Grid Laser and Panretinal Photocoagulation in Patients With Diabetic Macula Edema

NCT02131350

Phase 4 Completed 40 enrolled Shinshu University
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the mean gain in best corrected visual acuity and the number of intravitreal ranibizumab (IVR) injections under the combination treatment of IVR, focal/grid laser and panretinal photocoagulation. Our hypothesis is that suitable photocoagulation decreases the number of IVR injections.

Timeline

Start
2014-04
Primary completion
2017-03
Completion
2018-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Ranibizumab Monoclonal antibody Intravitreal